A Randomised, Phase II Study to Evaluate the sAfety and Pharmacokinetics of oraL dabIGatran Etexilate in Patients After Heart Valve replacemeNt
A Randomised, Phase II Study to Evaluate the sAfety and Pharmacokinetics of oraL dabIGatran Etexilate in Patients After Heart Valve replacemeNt
To validate the dosing algorithm for dabigatran etexilate in patients receiving a mechanical heart valve.
Inclusion criteria:
Exclusion criteria: